Naltrexone plus acamprosate for long-term management of alcohol dependence

Evidence of benefit is insufficient to recommend a combination of naltrexone and acamprosate as a standard treatment in preventing relapse, although evidence from rates of hospital admissions supports it being safeHeikkinen, 2021. Consider prescribing a trial of the combination when documented treatment with each drug alone has not achieved the desired result.